Loading…
The Label Matters: μPET Imaging of the Biodistribution of Low Molar Mass 89 Zr and 18 F-Labeled Poly(2-ethyl-2-oxazoline)
Poly(2-alkyl-2-oxazoline)s (PAOx) have received increasing interest for biomedical applications. Therefore, it is of fundamental importance to gain an in-depth understanding of the biodistribution profile of PAOx. We report the biodistribution of poly(2-ethyl-2-oxazoline) (PEtOx) with a molar mass o...
Saved in:
Published in: | Biomacromolecules 2017-01, Vol.18 (1), p.96-102 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Poly(2-alkyl-2-oxazoline)s (PAOx) have received increasing interest for biomedical applications. Therefore, it is of fundamental importance to gain an in-depth understanding of the biodistribution profile of PAOx. We report the biodistribution of poly(2-ethyl-2-oxazoline) (PEtOx) with a molar mass of 5 kDa radiolabeled with PET isotopes
Zr and
F.
F-labeled PEtOx is prepared by the strain-promoted azide-alkyne cycloaddition (SPAAC) of [
F]fluoroethylazide to bicyclo[6.1.0]non-4-yne (BCN)-functionalized PEtOx as many common labeling strategies were found to be unsuccessful for PEtOx.
Zr-labeled PEtOx is prepared using desferrioxamine end-groups as a chelator. Five kDa PEtOx shows a significantly faster blood clearance compared to PEtOx of higher molar mass while uptake in the liver is lower, indicating a minor contribution of the liver in excretion of the 5 kDa PEtOx. While [
F]-PEtOx displays a rapid and efficient clearance from the kidneys, 5 kDa [
Zr]-Df-PEtOx is not efficiently cleared over the time course of the study, which is most likely caused by trapping of
Zr-labeled metabolites in the renal tubules and not the polymer itself, demonstrating the importance of selecting the appropriate label for biodistribution studies. |
---|---|
ISSN: | 1525-7797 1526-4602 |
DOI: | 10.1021/acs.biomac.6b01392 |